Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. InMed Pharmaceuticals Inc shares valued at $42 were sold by MANCINI ALEXANDRA DIANE JANET on Jul 31 ’24. At $0.18 per share, MANCINI ALEXANDRA DIANE JANET sold 240 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, HULL ANDREW purchased 37,500 shares, netting a total of over 14,625 in proceeds. Following the buying of shares at $0.39 each, the insider now holds 38,258 shares.
Before that, ADAMS ERIC A had added 41,600 shares to its account. In a trade valued at $14,922, the President & CEO bought InMed Pharmaceuticals Inc shares for $0.36 each. Upon closing the transaction, the insider’s holdings increased to 41,600 shares, worth approximately $0.2 million.
Analyzing INM Stock Performance
During the last five days, there has been a drop of approximately -4.85%. Over the course of the year, InMed Pharmaceuticals Inc shares have dropped approximately -4.85%. Shares of the company reached a 52-week high of $5.41 on 01/06/25 and a 52-week low of $4.11 on 01/08/25. A 50-day SMA is recorded $4.83, while a 200-day SMA reached $5.24. Nevertheless, trading volume fell to 94477.0 shares from 20200.0 shares the previous day.
Support And Resistance Levels for InMed Pharmaceuticals Inc (INM)
According to the 24-hour chart, there is a support level at 4.12, which, if violated, would cause prices to drop to 3.73. In the upper region, resistance lies at 4.89. The next price resistance is at 5.26. RSI (Relative Strength Index) is 44.46 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.12, which suggests the price will decrease in the coming days. Percent R is at 69.24%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
